Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 13 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (8)

Trial Status

Recruiting6
Completed4
Active Not Recruiting1
Unknown1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT07657897Not ApplicableRecruiting

The Impact of Anaesthesia and Sedation on Inflammation and NETosis in Hepatocellular Carcinoma Ablation

NCT07642986Not ApplicableCompleted

Diagnosis and Treatment of Lung Lesions

NCT07625189Recruiting

EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesions Registry

NCT07237399Withdrawn

Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM)

NCT07291271Completed

Use of Flow-Controlled Ventilation During CT-Guided Percutaneous Liver Tumor Ablation

NCT07214363Not ApplicableActive Not Recruiting

The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver Cancers

NCT07141745Not ApplicableRecruiting

Electroporation vs. Radiofrequency Ablation Guided by 3D Imaging in Repeat Procedures for Atrial Fibrillation

NCT07109141Recruiting

Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland

NCT06734312Not ApplicableRecruiting

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

NCT06802510Not ApplicableCompleted

The Safety and Efficacy of Combined Microwave Ablation During Limb-sparing Surgery in High-risk Soft Tissue Sarcoma Patients

NCT06356779Not ApplicableRecruiting

Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease

NCT05495529Completed

Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors

NCT03223142Not ApplicableUnknown

Standardization of Multi-modal Tumor Ablation Therapy System

Showing all 13 trials

Research Network

Activity Timeline